Pan-Canadian review of cancer drugs will not be binding on provinces

被引：3
作者：
Vogel, Lauren
机构：
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2010年 / 182卷 / 09期
关键词：
D O I：
10.1503/cmaj.109-3262
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：887 / 888
页数：2
相关论文
共 50 条
[41]   PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer Consortium [J].
Bosse, Dominick ;
Mercer, Jamison ;
Raissouni, Soundouss ;
Dennis, Kristopher ;
Goodwin, Rachel ;
Jiang, Di ;
Powell, Erin ;
Kumar, Aalok ;
Lee-Ying, Richard ;
Price-Hiller, Julie ;
Heng, Daniel Y. C. ;
Tang, Patricia A. ;
MacLean, Anthony ;
Cheung, Winson Y. ;
Vickers, Michael M. .
CLINICAL COLORECTAL CANCER, 2016, 15 (03) :243-249
[42]   The prioritization preferences of pan-Canadian Oncology Drug Review members and the Canadian public: a stated-preferences comparison [J].
Skedgel, C. .
CURRENT ONCOLOGY, 2016, 23 (05) :322-328
[43]   Impact of the pan-Canadian Oncology Drug Review on provincial concordance with respect to cancer drug funding decisions and time to funding [J].
Srikanthan, A. ;
Mai, H. ;
Penner, N. ;
Amir, E. ;
Laupacis, A. ;
Sabharwal, M. ;
Chan, K. K. W. .
CURRENT ONCOLOGY, 2017, 24 (05) :295-301
[44]   Clinician participation in CADTH's pan-Canadian Oncology Drug Review: contribution and impact on cancer drug funding recommendations [J].
Trudeau, M. ;
Hoskins, P. ;
Reiman, T. ;
Chambers, A. ;
Mai, H. ;
Wheatley-Price, P. .
CURRENT ONCOLOGY, 2017, 24 (02) :71-74
[45]   THE MANAGEMENT OF SMALL CELL LUNG CANCER WITH RADIOTHERAPY - A PAN-CANADIAN SURVEY OF RADIATION ONCOLOGISTS [J].
Shahi, Jeevin ;
Wright, James ;
Gabos, Zsolt ;
Swaminath, Anand .
RADIOTHERAPY AND ONCOLOGY, 2016, 120 :S87-S87
[46]   PROSPECT eligibility and clinical outcomes: Results from the pan-Canadian rectal cancer consortium [J].
Bosse, Dominick ;
Mercer, Jamison ;
Raissouni, Soundouss ;
Dennis, Kristopher ;
Goodwin, Rachel Anne ;
Jiang, Maria ;
Powell, Erin Diana ;
Kumar, Aalok ;
Lee-Ying, Richard M. ;
Hiller, Julie A. Price ;
Heng, Daniel Yick Chin ;
Tang, Patricia A. ;
MacLean, Anthony ;
Cheung, Winson Y. ;
Vickers, Michael M. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[47]   Research, Practice, and Policy Partnerships in Pan-Canadian Coalitions for Cancer and Chronic Disease Prevention [J].
Manafo, Elizabeth ;
Petermann, Lisa ;
Lobb, Rebecca ;
Keen, Deb ;
Kerner, Jon .
JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2011, 17 (06) :E1-E11
[48]   POSITIVE CANCER DRUG RECOMMENDATIONS BY THE PAN-CANADIAN ONCOLOGY DRUG REVIEW ARE NOT WITHOUT CONDITIONS PLACED ON COST-EFFECTIVENESS [J].
Grima, A. ;
Whitney, S. ;
Samjoo, I ;
Grima, D. .
VALUE IN HEALTH, 2018, 21 :S47-S47
[49]   Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs [J].
Saluja, Ronak ;
Jiao, Tina ;
Koshy, Liza ;
Cheung, Matthew ;
Chan, Kelvin K. W. .
CURRENT ONCOLOGY, 2021, 28 (01) :606-618
[50]   Recommendations for the safe use and handling of oral anticancer drugs in community pharmacy: A pan-Canadian consensus guideline [J].
Vu, Kathy ;
Emberley, Philip ;
Brown, Erika ;
Abbott, Rick ;
Bates, Justin J. ;
Bourrier, Venetia ;
Djordjevic, Kathryn ;
Greenall, Julie ;
Leung, Mova ;
Pasetka, Mark ;
Paquet, Louise ;
Logan, Heather .
CANADIAN PHARMACISTS JOURNAL, 2018, 151 (04) :240-253
12345